Johanna B Holm, Kayla A Carter, Jacques Ravel, Rebecca M Brotman
{"title":"阴道乳杆菌与生殖器健康:神秘阴道物种的分子线索。","authors":"Johanna B Holm, Kayla A Carter, Jacques Ravel, Rebecca M Brotman","doi":"10.1007/s11908-023-00798-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>Vaginal lactobacilli are recognized as important drivers of genital health including protection against bacterial vaginosis and sexually transmitted infections. <i>Lactobacillus iners</i> is distinct from <i>L. crispatus, L. gasseri</i>, and <i>L. jensenii</i> by its high global prevalence in vaginal microbiomes, relatively small genome, production of only L-lactic acid, and inconsistent associations with genital health outcomes. In this review, we summarize our current understanding of the role of <i>L. iners</i> in the vaginal microbiome, highlight the importance of strain-level consideration for this species, and explain that while marker gene-based characterization of the composition of the vaginal microbiota does not capture strain-level resolution, whole metagenome sequencing can aid in expanding our understanding of this species in genital health.</p><p><strong>Recent findings: </strong><i>L. iners</i> exists in the vaginal microbiome as a unique combination of strains. The functional repertoires of these strain combinations are likely wide and contribute to the survival of this species in a variety of vaginal microenvironments. In published studies to date, strain-specific effects are aggregated and may yield imprecise estimates of risk associated with this species.</p><p><strong>Summary: </strong>The worldwide high prevalence of <i>Lactobacillus iners</i> warrants more research into its functional roles in the vaginal microbiome and how it may directly impact susceptibility to infections. By incorporating strain-level resolution into future research endeavors, we may begin to appreciate <i>L. iners</i> more thoroughly and identify novel therapeutic targets for a variety of genital health challenges.</p>","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":"25 4","pages":"67-75"},"PeriodicalIF":3.1000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209668/pdf/nihms-1896832.pdf","citationCount":"0","resultStr":"{\"title\":\"<i>Lactobacillus iners</i> and genital health: molecular clues to an enigmatic vaginal species.\",\"authors\":\"Johanna B Holm, Kayla A Carter, Jacques Ravel, Rebecca M Brotman\",\"doi\":\"10.1007/s11908-023-00798-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose of review: </strong>Vaginal lactobacilli are recognized as important drivers of genital health including protection against bacterial vaginosis and sexually transmitted infections. <i>Lactobacillus iners</i> is distinct from <i>L. crispatus, L. gasseri</i>, and <i>L. jensenii</i> by its high global prevalence in vaginal microbiomes, relatively small genome, production of only L-lactic acid, and inconsistent associations with genital health outcomes. In this review, we summarize our current understanding of the role of <i>L. iners</i> in the vaginal microbiome, highlight the importance of strain-level consideration for this species, and explain that while marker gene-based characterization of the composition of the vaginal microbiota does not capture strain-level resolution, whole metagenome sequencing can aid in expanding our understanding of this species in genital health.</p><p><strong>Recent findings: </strong><i>L. iners</i> exists in the vaginal microbiome as a unique combination of strains. The functional repertoires of these strain combinations are likely wide and contribute to the survival of this species in a variety of vaginal microenvironments. In published studies to date, strain-specific effects are aggregated and may yield imprecise estimates of risk associated with this species.</p><p><strong>Summary: </strong>The worldwide high prevalence of <i>Lactobacillus iners</i> warrants more research into its functional roles in the vaginal microbiome and how it may directly impact susceptibility to infections. By incorporating strain-level resolution into future research endeavors, we may begin to appreciate <i>L. iners</i> more thoroughly and identify novel therapeutic targets for a variety of genital health challenges.</p>\",\"PeriodicalId\":48839,\"journal\":{\"name\":\"Current Infectious Disease Reports\",\"volume\":\"25 4\",\"pages\":\"67-75\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209668/pdf/nihms-1896832.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Infectious Disease Reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11908-023-00798-5\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/3/7 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Infectious Disease Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11908-023-00798-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/3/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
摘要
综述的目的:阴道乳杆菌被认为是生殖器健康的重要驱动力,包括防止细菌性阴道病和性传播感染。阴道乳杆菌(Lactobacillus iners)与L. crispatus、L. gasseri和L. jensenii不同,它在全球阴道微生物组中的流行率很高,基因组相对较小,只产生L-乳酸,而且与生殖器健康结果的关系不一致。在这篇综述中,我们总结了目前我们对 L. iners 在阴道微生物群中作用的理解,强调了考虑菌株水平对该物种的重要性,并解释说,虽然基于标记基因的阴道微生物群组成特征描述不能捕捉到菌株水平的分辨率,但全基因组测序有助于扩大我们对该物种在生殖器健康中作用的理解:最新研究结果:阴道微生物群中的 L. iners 是一种独特的菌株组合。这些菌株组合的功能范围可能很广,有助于该物种在各种阴道微环境中生存。小结:阴道乳杆菌在全球范围内的高流行率需要对其在阴道微生物组中的功能作用以及如何直接影响感染易感性进行更多的研究。通过将菌株级分辨率纳入未来的研究工作,我们可能会开始更透彻地了解内氏乳杆菌,并确定新的治疗目标,以应对各种生殖健康挑战。
Lactobacillus iners and genital health: molecular clues to an enigmatic vaginal species.
Purpose of review: Vaginal lactobacilli are recognized as important drivers of genital health including protection against bacterial vaginosis and sexually transmitted infections. Lactobacillus iners is distinct from L. crispatus, L. gasseri, and L. jensenii by its high global prevalence in vaginal microbiomes, relatively small genome, production of only L-lactic acid, and inconsistent associations with genital health outcomes. In this review, we summarize our current understanding of the role of L. iners in the vaginal microbiome, highlight the importance of strain-level consideration for this species, and explain that while marker gene-based characterization of the composition of the vaginal microbiota does not capture strain-level resolution, whole metagenome sequencing can aid in expanding our understanding of this species in genital health.
Recent findings: L. iners exists in the vaginal microbiome as a unique combination of strains. The functional repertoires of these strain combinations are likely wide and contribute to the survival of this species in a variety of vaginal microenvironments. In published studies to date, strain-specific effects are aggregated and may yield imprecise estimates of risk associated with this species.
Summary: The worldwide high prevalence of Lactobacillus iners warrants more research into its functional roles in the vaginal microbiome and how it may directly impact susceptibility to infections. By incorporating strain-level resolution into future research endeavors, we may begin to appreciate L. iners more thoroughly and identify novel therapeutic targets for a variety of genital health challenges.
期刊介绍:
This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of infectious disease.
We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as HIV/AIDS, sexually transmitted diseases, tropical and travel medicine, and urinary tract infections. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists.